Please use this identifier to cite or link to this item: https://doi.org/10.1080/10508422.2016.1189333
Title: Ethical Considerations for Clinical Research and Off-label Use of Ketamine to Treat Mood Disorders: The Balance between Risks and Benefits
Authors: Melvyn Zhang
Roger Ho 
Issue Date: 10-Jun-2016
Publisher: Taylor & Francis
Citation: Melvyn Zhang, Roger Ho (2016-06-10). Ethical Considerations for Clinical Research and Off-label Use of Ketamine to Treat Mood Disorders: The Balance between Risks and Benefits. Ethics & Behavior 27 (8) : 681-699. ScholarBank@NUS Repository. https://doi.org/10.1080/10508422.2016.1189333
Source Title: Ethics & Behavior
URI: http://scholarbank.nus.edu.sg/handle/10635/141061
ISSN: 1050-8422
DOI: 10.1080/10508422.2016.1189333
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10.108010508422.2016.1189333.zip91.42 kBZIP

OPEN

NoneView/Download

Page view(s)

10
checked on Nov 15, 2018

Download(s)

15
checked on Nov 15, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.